News
Learn more about how C3i takes part in the development of new cell and gene therapies.
-
Nov 13, 2017
C3i’s Biomarker and Diagnostic unit now offers TCR-beta sequencing services
Read MoreThe Center for Commercialization of Cancer Immunotherapy (C3i) is proud to announce the availability of T cell receptor-beta sequencing services in its Biomarker and Diagnostic unit.
-
Sep 30, 2017
C3i participates to the challenge Cycle for a Cure!
Read MoreThe 6th edition of the Bike Challenge for Cellular Therapy Research at the Maisonneuve-Rosemont Hospital will give you the opportunity to support scientific work that promotes healing.